Drug intelligence / Profile preview

Bloodwin

Development stage: Unknown
Lead developer: SKM Siddha and Ayurveda Company
Modality: Small Molecules
Administration: Oral

Overview

Bloodwin (also marketed as Bloddwin Syrup) is a traditional Ayurvedic herbal formulation developed and manufactured by SKM Siddha and Ayurveda Company (India) Private Limited. Launched in 2022, it is designed to treat iron deficiency and anemia by increasing hemoglobin levels in the blood. The formulation also aims to renormalize appetite and facilitate digestion and nutrient absorption. As a polyherbal product, it combines various natural herbal extracts to provide both therapeutic and nutritional benefits. The manufacturer, SKM Siddha and Ayurveda Company, is an ISO-GMP certified entity specializing in Siddha, Ayurveda, and Unani medicines.

Brand names: BloodwinBloddwin Syrup
Other names: Bloddwin Syrup

Beyond the preview

Go deeper on Bloodwin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bloodwin.

Explore the full profile